27
total announcements
MANGALAM.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹48 Cr
EPS (TTM)
₹-24.16
52W Low
₹22.80
52W High
₹73.00
Dividend Yield
0.00%
Beta
0.32
Price / Book
0.5
Debt / Equity
109.4
Revenue (TTM)
₹232 Cr
Gross Margin
35.16%
Operating Margin
-5.38%
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange about default on bank loan account to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange about a newspaper publication regarding a postal ballot and e-voting for a special business.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange regarding Notice of Postal Ballot for the appointment of Shri Prabhakar Raghunath Zavar as an Independent Director of the Company for a Term of Five consecutive years.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange regarding Change in Auditors of the company. The company has appointed M/s LN. Joshi & Co as Secretarial Auditors and M/s S.N. Nanda & Co as Statutory Auditor for a period of 5 consecutive years.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange about change in Management, including the appointment of new Secretarial Auditors and Statutory Auditors, and the retirement of the previous Statutory Auditor.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange about the retirement of M/s V.S. Somani and Co., Chartered Accountants, as Statutory Auditor of the Company in line with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) (Third Amendment) Regulations, 2024, consequent upon the completion of their term.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange regarding the appointment of S.N Nanda & Co. as Statutory Auditor and L.N. Joshi & Co. as Secretarial Auditors for a period of 5 years.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on September 23, 2026.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange regarding voting results of Annual General Meeting held on September 23, 2026. All resolutions were duly passed by the members of the Company with requisite majority.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 23, 2026.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange about default on its loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has appointed Mr. Prabhakar Raghunath Zavar as a Non-Executive Independent Director for a term of five years, subject to shareholder approval.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange regarding the appointment of Mr. Prabhakar Raghunath Zavar as an Additional Director (Independent Non-Executive Director) of the Company for a term of five consecutive years, subject to the approval of shareholders at the ensuing Extra-Ordinary General Meeting.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange about Copy of Newspaper Publication regarding Notice of 53rd Annual General Meeting and Information on E-voting.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 23, 2026.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange about defaulting on its loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange about the publication of Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026, as per Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited has informed the Exchange regarding Change in Auditors of the company. The company has appointed M/s SN. Nanda & Co as the Statutory Auditors for a term of five consecutive years, commencing from the conclusion of the 53rd AGM till the conclusion of the 58th AGM, subject to the approval of the shareholders at the ensuing AGM.